Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatm...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English English |
| Published: |
Division of Chemical and Systems Biology
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613274100465664 |
|---|---|
| access_status_str | Open Access |
| author | Frankle, Solyle |
| author2 | Sinkala, Musalula |
| author_browse | Frankle, Solyle Sinkala, Musalula |
| author_facet | Sinkala, Musalula Frankle, Solyle |
| author_sort | Frankle, Solyle |
| collection | Thesis |
| description | Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatment strategies. Breast cancer remains one of the most prevalent cancers affecting women globally, with early and accurate diagnosis being crucial for effective treatment. AI, through its advanced image analysis capabilities, significantly improves the accuracy and efficiency of breast cancer diagnosis, specifically in distinguishing between cancer subtypes. Here, we aim to explore the application of deep learning, particularly convolutional neural networks (CNNs), in breast cancer subtype classification using histology images. A custom CNN model, alongside well-established models like ResNet50 and EfficientNetB0, was developed and evaluated for its accuracy in predicting benign and malignant breast cancer subtypes. The results demonstrated that while the custom CNN achieved an accuracy of 65% for malignant and 67% for benign subtypes with ROC-AUC scores of 0.86 and 0.90, respectively, ResNet50 significantly outperformed both the custom model and EfficientNetB0. ResNet50 attained an accuracy of 77% in classifying malignant subtypes and 77% for benign subtypes, accompanied by ROC-AUC scores of 0.92 and 0.96, respectively. Additionally, ResNet50 exhibited higher precision (0.68 for malignant, 0.67 for benign), recall (0.65 for malignant, 0.67 for benign), and F1 scores (0.65 for malignant, 0.67 for benign) across most subtypes, underscoring its robust performance and reliability in clinical settings. In conclusion, AI, specifically through advanced CNN architectures, can greatly enhance breast cancer diagnosis by providing more accurate subtype classifications. Future work should focus on integrating these models into clinical workflows, enabling faster and more personalised treatment planning. Moreover, continued refinement of these models, including addressing the complexities of tumour heterogeneity and incorporating multimodal data, will be crucial for their widespread adoption in oncology. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/42289 |
| institution | University of Cape Town (South Africa) |
| language | English eng |
| last_indexed | 2026-06-10T12:33:31.121Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | Division of Chemical and Systems Biology |
| publisherStr | Division of Chemical and Systems Biology |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/42289 Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures Frankle, Solyle Sinkala, Musalula Breast Cancer CNN AI Artificial Intelligence (AI), particularly its machine learning (ML) subfield, has revolutionised various sectors, including healthcare. In breast cancer care, AI's ability to analyse vast datasets and extract complex patterns from medical images has the potential to transform diagnostics and treatment strategies. Breast cancer remains one of the most prevalent cancers affecting women globally, with early and accurate diagnosis being crucial for effective treatment. AI, through its advanced image analysis capabilities, significantly improves the accuracy and efficiency of breast cancer diagnosis, specifically in distinguishing between cancer subtypes. Here, we aim to explore the application of deep learning, particularly convolutional neural networks (CNNs), in breast cancer subtype classification using histology images. A custom CNN model, alongside well-established models like ResNet50 and EfficientNetB0, was developed and evaluated for its accuracy in predicting benign and malignant breast cancer subtypes. The results demonstrated that while the custom CNN achieved an accuracy of 65% for malignant and 67% for benign subtypes with ROC-AUC scores of 0.86 and 0.90, respectively, ResNet50 significantly outperformed both the custom model and EfficientNetB0. ResNet50 attained an accuracy of 77% in classifying malignant subtypes and 77% for benign subtypes, accompanied by ROC-AUC scores of 0.92 and 0.96, respectively. Additionally, ResNet50 exhibited higher precision (0.68 for malignant, 0.67 for benign), recall (0.65 for malignant, 0.67 for benign), and F1 scores (0.65 for malignant, 0.67 for benign) across most subtypes, underscoring its robust performance and reliability in clinical settings. In conclusion, AI, specifically through advanced CNN architectures, can greatly enhance breast cancer diagnosis by providing more accurate subtype classifications. Future work should focus on integrating these models into clinical workflows, enabling faster and more personalised treatment planning. Moreover, continued refinement of these models, including addressing the complexities of tumour heterogeneity and incorporating multimodal data, will be crucial for their widespread adoption in oncology. 2025-11-21T06:49:43Z 2025-11-21T06:49:43Z 2025 2025-11-21T06:46:50Z Thesis / Dissertation Masters MSc http://hdl.handle.net/11427/42289 en eng application/pdf Division of Chemical and Systems Biology Faculty of Health Sciences University of Cape Town |
| spellingShingle | Breast Cancer CNN AI Frankle, Solyle Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| thesis_degree_str | Master's |
| title | Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| title_full | Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| title_fullStr | Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| title_full_unstemmed | Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| title_short | Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures |
| title_sort | evaluating deep learning for enhanced breast cancer diagnosis a comparative analysis of cnn architectures |
| topic | Breast Cancer CNN AI |
| url | http://hdl.handle.net/11427/42289 |
| work_keys_str_mv | AT franklesolyle evaluatingdeeplearningforenhancedbreastcancerdiagnosisacomparativeanalysisofcnnarchitectures |